Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$618.46 USD

618.46
1,324,097

-5.75 (-0.92%)

Updated Sep 11, 2024 04:00 PM ET

After-Market: $618.47 +0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

IDEXX (IDXX) Earnings Beat Estimates in Q2, Margins Rise

IDEXX Laboratories (IDXX) registered strong contribution from its CAG business despite the pandemic-led challenges.

Teleflex (TFX) Beats Q2 Earnings Estimates, Margins Contract

Teleflex (TFX) sales grow within the Americas attributable to Vascular Access and respiratory products, driven by COVID-19-led elevated demand.

DaVita (DVA) Earnings Beat Estimates in Q2, Revenues Miss

DaVita's (DVA) dialysis services in the United States were solid in Q2.

Exact Sciences' (EXAS) Q2 Earnings Beat, Margin Declines

Exact Sciences' (EXAS) legacy screening business sees a decline in revenues in Q2 earnings.

NextGen Healthcare (NXGN) Tops Q1 Earnings & Revenue Estimates

NextGen (NXGN) benefited from its Recurring segment in Q1.

Bio-Rad (BIO) Q2 Earnings Beat Estimates, Gross Margin Rises

Bio-Rad's (BIO) second-quarter 2020 results reflect strong performance by the Life Sciences segment, boosted by coronavirus-led increased testing demand.

Tandem Diabetes (TNDM) Q2 Earnings & Revenues Top Estimates

Tandem Diabetes' (TNDM) strong domestic pump sales and pump shipments boosted the top line.

Integer Holdings (ITGR) Q2 Earnings Miss Estimates, Down Y/Y

Integer Holdings' (ITGR) second-quarter results reflect from weak segmental performance and margin contraction.

Stryker (SYK) Q2 Earnings and Revenues Surpass Estimates

Stryker's (SYK) second-quarter earnings reflect weak segmental performance.

OPKO Health (OPK) Q2 Earnings and Revenues Beat Estimates

OPKO Health's (OPK) second-quarter results benefit from increase in RAYALDEE prescriptions.

Chemed (CHE) Q2 Earnings Beat Estimates, Margins Decline

Chemed (CHE) witnesses solid revenue growth across key subsidiaries in Q2 earnings.

CONMED (CNMD) Q2 Loss Narrower Than Expected, Revenues Top

CONMED's (CNMD) core units - General Surgery and Orthopedic Surgery - witnessed revenue decline in Q2.

Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates

Merit Medical (MMSI) reported a drop in revenues at every key operating segment in Q2.

Hologic (HOLX) Q3 Earnings Surpass Estimates, Margins Rise

Hologic (HOLX) exhibited robust segmental growth in third-quarter fiscal 2020 driven by strong performance by the Diagnostics segment amid the coronavirus pandemic.

Baxter (BAX) Earnings and Revenues Miss Estimates in Q2

Baxter's (BAX) second-quarter earnings reflect weak performance across Medication Delivery, Pharmaceutical and Advanced Surgery business units and contraction in margins.

Cerner (CERN) Q2 Earnings Surpass Estimates, Revenues Miss

Cerner (CERN) second-quarter results benefit from gains in Subscriptions and Managed services units, and expansion in margins.

The Zacks Analyst Blog Highlights: Turning Point Brands, Medifast, Emergent BioSolutions, Thermo Fisher Scientific and Sempra Energy

The Zacks Analyst Blog Highlights: Turning Point Brands, Medifast, Emergent BioSolutions, Thermo Fisher Scientific and Sempra Energy

The Zacks Analyst Blog Highlights: Microsoft, Tesla, Thermo Fisher Scientific, ABB and Suncor Energy

The Zacks Analyst Blog Highlights: Microsoft, Tesla, Thermo Fisher Scientific, ABB and Suncor Energy

Sreoshi Bera headshot

Jobless Claims Rise First Time Since March: 5 Defensive Picks

The spike in unemployment claims and looming coronavirus fears have made markets volatile, making defensive picks lucrative investment options.

Sheraz Mian headshot

Top Stock Reports for Microsoft, Tesla & Thermo Fisher

Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Tesla (TSLA) and Thermo Fisher Scientific (TMO).

Company News for Jul 23, 2020

Companies In The News Are: HCA, TMO, ABB, APH.

John Blank headshot

Should You Buy the Rally in Non-US Stocks?

Or does global growth need to show up first???

Has Thermo Fisher Scientific (TMO) Outpaced Other Medical Stocks This Year?

Is (TMO) Outperforming Other Medical Stocks This Year?

Thermo Fisher (TMO) Q2 Earnings Beat on COVID-19-Led Sales

We are encouraged about Thermo Fisher's (TMO) exceptionally strong year-over-year revenue growth at Life Sciences Solutions segment.

Here's Why You Should Add QIAGEN (QGEN) to Your Portfolio

Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth.